Clinical Trial Update: Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized open-label trial compares combination therapy followed by maintenance chemotherapy versus a CDK4/6 inhibitor combined with endocrine therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitor
• Chemotherapy (maintenance following combination)
• Endocrine therapy

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Advanced Breast Cancer, Treatment | Phase 2 | Status: RECRUITING